Marlene Milgram

Marlene Milgram serves as a secondary procurement contact within the Department of Health and Human Services, supporting the acquisition of high-precision medical and laboratory instrumentation critical to public health infrastructure. While not the primary contracting officer, she plays a vital role in facilitating the procurement lifecycle for specialized scientific equipment, ensuring alignment with the agency’s mission to advance diagnostic innovation and biotechnological research capacity. Her responsibilities include coordinating requirements validation, vendor engagement, and contract administration for complex technical acquisitions, particularly in molecular diagnostics and analytical instrumentation. She works closely with senior contracting teams to ensure compliance with federal procurement regulations and technical specifications. Milgram maintains consistent procurement relationships with leading providers of medical and laboratory technology, including Leidos Biomedical Research Inc., General Dynamics Information Technology, Advanced Technology International, and Rapid Deployment Inc. These partnerships reflect a preference for established contractors with proven expertise in biomedical R&D support, laboratory automation, and high-throughput diagnostic systems. Her working patterns emphasize long-term vendor collaboration, technical due diligence, and performance-based contract management to ensure operational readiness of critical health infrastructure. Milgram’s procurement portfolio shows no use of socioeconomic set-asides, with 100% of acquisitions awarded under full and open competition. This reflects a strategic emphasis on technical capability and mission-critical performance over socioeconomic preferences, aligning with the agency’s priority to secure the highest-quality scientific equipment without restriction. Her primary procurement focus lies in NAICS 339112 (Surgical and Medical Instrument Manufacturing) and 334516 (Analytical Laboratory Instrument Manufacturing), indicating deep expertise in acquiring precision devices such as PCR analyzers, mass spectrometers, flow cytometers, and automated clinical diagnostic systems. She specializes in procuring instruments that support molecular diagnostics, genomic research, and laboratory accreditation standards, ensuring the agency’s research and response capabilities remain at the forefront of biomedical innovation.